ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Good data. Now I have a rich set of confirmed earnings events. No IPOs in the pipeline. Let me write the article.

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Good data. Now I have a rich set of confirmed earnings events. No IPOs in the pipeline. Let me write the article.

Retailers and Tech Dominate This Week's Calendar

A busy week of earnings kicks off today, Friday May 22, with several smaller names reporting. The big action starts Tuesday.

Tuesday, May 26, AZO AutoZone posts Q3 results. The auto parts giant has beaten estimates in nine straight quarters.

Wednesday, May 27 is the week's heaviest day. CRM Salesforce reports Q1 2027 results after the bell. AI-driven demand for its cloud platform is the key focus. MRVL Marvell Technology also reports Wednesday. The chipmaker has been a major AI infrastructure beneficiary. SNPS Synopsys drops Q2 numbers the same evening. HPQ HP Inc. rounds out the tech wave with Q2 results. DKS Dick's Sporting Goods hosts its Q1 2027 earnings call Wednesday morning.

Thursday, May 28 brings COST Costco's Q3 release — arguably the week's marquee event. Membership trends and consumer resilience are in focus. DLTR Dollar Tree reports the same day. The discount retailer is under pressure after recent restructuring. ADSK Autodesk and NTAP NetApp both post Q1 and Q4 results respectively.

Canadian banks also feature prominently. BMO Bank of Montreal reports Tuesday. RY Royal Bank of Canada and TD TD Bank follow Thursday.

No significant IPOs are scheduled in the next seven days.

How this article was generated

Generated
22 May 2026, 04:32
Prompt version
v1.0
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.